The Antirheumatic Drug Gold, A Coin with Two Faces: AU(I) and AU(III). Desired and Undesired Effects on the Immune System
1994

The Antirheumatic Drug Gold: Effects on the Immune System

publication Evidence: moderate

Author Information

Author(s): Kazuo Takahashi, Peter Griem, Carsten Goebel, Jose Gonzalez, Ernst Gleichmann

Primary Institution: Division of Immunology, Medical Institute of Environmental Hygiene at Heinrich Heine University Düsseldorf

Hypothesis

How do antirheumatic Au(I) drugs affect the immune system?

Conclusion

Au(I) and Au(III) have distinct effects on macrophages and T cell activation, explaining both the therapeutic and adverse effects of gold drugs.

Supporting Evidence

  • Au(I) drugs inhibit T cell activation by interfering with antigen processing.
  • Au(I) is oxidized to Au(III) in phagocytic cells, which may lead to adverse immune reactions.
  • Gold drugs can create new immune responses by altering self proteins.

Takeaway

Gold drugs can help treat arthritis but can also cause unwanted immune reactions. They work by changing how the immune system recognizes certain proteins.

Methodology

The study involved reviewing findings on the mechanisms of action of Au(I) drugs and their effects on immune cells.

Limitations

The exact mechanisms of action and the specific proteins affected by Au(I) drugs remain largely unknown.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication